CHIARITO, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 1.175
EU - Europa 410
AS - Asia 192
AF - Africa 34
SA - Sud America 4
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.818
Nazione #
US - Stati Uniti d'America 1.170
FI - Finlandia 150
CN - Cina 122
IE - Irlanda 92
IT - Italia 45
DE - Germania 43
IN - India 40
SE - Svezia 34
NG - Nigeria 32
FR - Francia 13
NL - Olanda 12
TH - Thailandia 7
TR - Turchia 7
RU - Federazione Russa 5
TW - Taiwan 5
BE - Belgio 4
GB - Regno Unito 4
CU - Cuba 3
JP - Giappone 3
PE - Perù 3
UA - Ucraina 3
CA - Canada 2
IR - Iran 2
RS - Serbia 2
UG - Uganda 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
CL - Cile 1
CY - Cipro 1
ES - Italia 1
HK - Hong Kong 1
ID - Indonesia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
Totale 1.818
Città #
Chandler 201
Helsinki 150
Shanghai 117
Wilmington 109
Dublin 92
Boardman 86
New York 76
Ashburn 51
San Mateo 51
Pune 37
Benin City 32
Los Angeles 28
Ann Arbor 23
Lawrence 23
Princeton 23
Leawood 17
Milan 15
Fairfield 14
Woodbridge 14
Amsterdam 12
Paris 10
Kocaeli 7
Turin 7
Redmond 6
Abbiategrasso 5
Falkenstein 5
Norwalk 5
Taipei 5
Brussels 4
Bangkok 3
Havana 3
Lima 3
Monza 3
Moscow 3
Mykolayiv 3
Phoenix 3
Phuket 3
San Diego 3
Carbonara al Ticino 2
Ho Chi Minh City 2
Kampala 2
London 2
Lübeck 2
Milwaukee 2
Procida 2
Seattle 2
Toronto 2
Belgrade 1
Brescia 1
Caloocan City 1
Chicago 1
Chisinau 1
Cowdenbeath 1
Cupertino 1
Gunzenhausen 1
Hangzhou 1
Henderson 1
Horn Lake 1
Hyderabad 1
Jakarta 1
Kashan 1
Kemerovo 1
Mladenovac 1
Nicosia 1
Perth 1
Pitesti 1
Redwood City 1
Rome 1
Sam Phran 1
San Severo 1
Tappahannock 1
Tauranga 1
Trentola-Ducenta 1
Tübingen 1
Zhoukou 1
Totale 1.298
Nome #
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 59
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 56
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 55
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 55
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 54
Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation 52
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 48
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry. 46
The synergy stent in high-bleeding risk patients: why design matters 44
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? Interv Cardiol. 43
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study. 43
Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli: The TAVI-SMALL Registry. 41
Safety and Efficacy of Polymer-Free Drug-Eluting Stents 41
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights from the BEAT International Collaborative Registrys 39
Left atrial appendage closure with the Ultraseal device: Initial experience and mid-term follow-up. 36
Acute coronary syndrome in a patient with a residual aortic dissection flap after supracoronary aortic replacement: the role of intravascular ultrasound 36
Clinical challenges in an unusual setting: ST-elevation in a patient suffering from graft versus host disease, between thrombosis and coronary spasm 36
Mitral Valve Stenosis after Transcatheter Aortic Valve Replacement: Case Report and Review of the Literature. 34
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials 32
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry 28
Characterization of Myocardial Injury in Patients With COVID-19 27
Antiplatelet therapy for secondary prevention of cardiovascular disease: challenging the certainties 26
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry) 25
Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel 24
Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 23
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey 22
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft 21
Direct oral anticoagulants versus Vitamin K antagonists in the treatment of left ventricular thrombosis: a systematic review and meta-analysis 21
Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials 20
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? 20
A Complicated Case of Resistant Hypertension 20
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 19
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention 18
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 18
The Cre8 amphilimus-eluting stent for the treatment of coronary artery disease: safety and efficacy profile 18
Lower dose direct oral anticoagulants and improved survival: A combined analysis in patients with established atherosclerosis 18
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 17
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 17
Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents 17
Drug-eluting stents in diabetic patients: Are we still treading water? 17
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 17
Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom 17
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis 16
Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside 16
Impact of complete revascularization on mortality in patients with ST-segment elevation myocardial infarction and multivessel disease: an updated meta-analysis 16
[Two-step strategy for the treatment of complex coronary artery disease and aortic stenosis in a patient with severely impaired left ventricular function] 15
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 15
Long-term prognostic impact of subclinical myocardial dysfunction in patients recovered from COVID-19 15
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 15
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis 15
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 14
Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry) 14
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 14
Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes 13
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding 13
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 13
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 12
Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI 12
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 12
Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care? 12
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent 11
Postoperative Delirium in Individuals Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis 11
Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry 11
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial 11
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis 11
Low-Dose Colchicine after Myocardial Infarction 10
Prognostic value of tricuspid regurgitation 10
Perioperative Management of P2Y12 Inhibitors in Patients Undergoing Cardiac Surgery within 1 Year of PCI 10
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction 10
Single or dual antiplatelet therapy after transcatheter aortic valve implantation. A meta-analysis of randomized controlled trials 10
Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold 10
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 9
Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience 9
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy 9
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI 9
One-year clinical outcome and predictors of ischemic and hemorrhagic events after percutaneous coronary intervention in elderly and very elderly patients 9
Panta rhei, also drug eluting stent technology 8
Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry 8
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 8
Stepwise use of circulatory support devices in a patient refractory to cardiopulmonary resuscitation 8
Types of myocardial injury and mid-term outcomes in patients with COVID-19 7
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 7
Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis 7
Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: A study-level meta-analysis 7
A sex paradox in clinical outcomes following complex percutaneous coronary intervention 7
Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli 7
Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization 6
Transcatheter aortic valve replacement in patients with end-stage renal disease: Is "better than nothing" good enough? 6
Sex-Related Differences in the Prevalence and Prognostic Value of the Academic Research Consortium for High Bleeding Risk Criteria 6
Long COVID-19 Cardiac Complications Are Associated With Autoimmunity to Cardiac Self-Antigens Sufficient to Cause Cardiac Dysfunction 6
Polymer-Free Biolimus-Eluting Stents or Polymer-Based Zotarolimus-Eluting Stents for Coronary Bifurcation Lesions 6
Left main coronary artery disease: when and how to perform PCI? 5
Polymer-free biolimus-A9-eluting stent performance according to renal impairment: insights from the RUDI-FREE registry 5
Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis 5
SGLT-2 inhibitors and cardiovascular outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis 5
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design 5
Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial 4
PROGNOSTIC VALUE OF HIGH-SENSITIVITY C-REATIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION 4
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 3
Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary Syndrome 2
Totale 1.874
Categoria #
all - tutte 16.386
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.386


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021222 1 1 3 0 1 50 38 12 57 33 0 26
2021/2022140 5 3 5 29 3 1 4 24 11 8 34 13
2022/2023776 56 18 33 99 76 51 16 49 157 107 84 30
2023/2024736 88 81 168 74 32 108 53 59 21 51 1 0
Totale 1.874